ACTA negotiates and advocates on behalf of the clinical trials sector with governments, health care policymakers and consumers on issues that impact the conduct of investigator-initiated clinical trials across the Australian health system.
Greater engagement and partnership between policymakers and clinical researchers significantly improves the process of generating high-quality evidence for new and existing clinical therapies at low marginal cost or with cost-savings.
- Working together with government, policymakers and consumers
ACTA is the peak body for clinical trial networks, clinical quality registries and clinical trial coordinating centres in Australia. We represent the investigator-initiated clinical trials sector.
Latest Resources
A precious investment: $20B future fund for medical research welcomed by the Australian Clinical Trials Alliance
ACTA activity work plan 2019 – 2020
ACTA Advisory Council minutes July 2017
ACTA Submission on draft Principles for accessing and using publicly funded data for health research
ACTA submission on revised table of standard costs for clinical trials
ACTA submission on safety monitoring & reporting of clincial trials in Australia
ACTA Submission on the MRFF Strategy & Priorities
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft
ACTA Submission to Senate Inquiry into Australia’s Innovation System
ACTA Submission to the Community Affairs Legislation Committee on the Medical Research Future Fund Bill 2015
ACTA Submission to The Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Costing Study
ACTA Submission to the Medicare Benefits Schedule Review Taskforce
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
ACTA Submission to the NHMRC Statement on Consumer & Community Involvement in Health & Medical Research: Public Consultation
ACTA Submission to the NHMRC Structural Review
ACTA Submission to the Select Committee on Health
ACTA sumbission to the ACSQHC on variation in healthcare
ACTA Summit 2016 – Dr Neil Soderlund
ACTA Summit 2016 – Opening address
ACTA welcomes Government commitment to get clinical trials back on track
ACTA Year in Review: Financial Year 2018/2019
Australian Clinical Trials Alliance welcomes Government commitment to get clinical trials back on track
Australian clinical trials networks shaping modern medicine: Local doctors recognised among the world’s most influential researchers of our time
Australian researchers pause with global counterparts to acknowledge vital role of clinical trials in saving lives and advancing medicine
Australian researchers pause with global counterparts to acknowledge vital role of clinical trials in saving lives and advancing medicine
Clinical effectiveness research: a critical need for health sector research governance capacity. MJA 2013
Clinical Quality Registries: A national approach
Economic evaluation of investigator-initiated clinical trials conducted by networks
First communique from the newly-formed Clinical Trials Advisory Committee (CTAC)
Forming networks for research: Proposal for an Australian Clinical Trials Alliance. MJA 2013
General practice-based clinical trials MJA 2013
How can clinical trials networks drive better translation of evidence into better quality care?
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
Opportunities for linking evidence development to reimbursement in Australia